The COVID-19 pandemic has led to an exponential increase in SARS-CoV-2 infections and associated deaths, and represents a significant challenge to healthcare professionals and facilities. Individual countries have taken several prevention and containment actions to control the spread of infection, including measures to guarantee safety of both healthcare professionals and patients who are at increased risk of infection from COVID-19. Faecal microbiota transplantation (FMT) has a well-established role in the treatment of Clostridioides difficile infection. In the time of the pandemic, FMT centres and stool banks are required to adopt a workflow that continues to ensure reliable patient access to FMT while maintaining safety and quality of procedures. In this position paper, based on the best available evidence, worldwide FMT experts provide guidance on issues relating to the impact of COVID-19 on FMT, including patient selection, donor recruitment and selection, stool manufacturing, FMT procedures, patient follow-up and research activities.

https://gut.bmj.com/content/gutjnl/69/9/1555.full.pdf

Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic.

Impact of COVID-19 on endoscopy trainees: an international survey.

Changes in Gastroenterology and Endoscopy Practices in Response to the Coronavirus Disease 2019 Pandemic: Results From a North American Survey.

/pdf/esge-and-esgena-position-statement-on-gastrointestinal-w6yolsn3nb.pdf

ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: An update on guidance during the post-lockdown phase and selected results from a membership survey.

Marco Dinelli

Papers

Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy.